<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Drugs associated with isolated thrombocytopenia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Drugs associated with isolated thrombocytopenia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Drugs associated with isolated thrombocytopenia</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Mechanism(s)</td> </tr> <tr> <td><strong>Abciximab</strong></td> <td>DITP</td> </tr> <tr> <td>Aceclofenac</td> <td>DITP</td> </tr> <tr> <td>Acetaminophen</td> <td>DITP; antibodies react with a drug metabolite, not the unmodified drug</td> </tr> <tr> <td>Alemtuzumab</td> <td>ITP*</td> </tr> <tr> <td>Amiodarone</td> <td>DITP</td> </tr> <tr> <td>Aspirin</td> <td>DITP</td> </tr> <tr> <td>Atezolizumab</td> <td>DITP</td> </tr> <tr> <td>Aztreonam</td> <td>DITP</td> </tr> <tr> <td><strong>Beta-lactam antibiotics (penicillins, cephalosporins, flucloxacillin)</strong></td> <td>DITP</td> </tr> <tr> <td>Bisoprolol</td> <td>DITP</td> </tr> <tr> <td><strong>Carbamazepine</strong></td> <td>DITP</td> </tr> <tr> <td>Ceftriaxone</td> <td>DITP</td> </tr> <tr> <td>Cetirizine</td> <td>DITP</td> </tr> <tr> <td>COVID-19 vaccines</td> <td>ITP, VITT (only adenoviral-vectored vaccines are known to cause VITT)</td> </tr> <tr> <td>Daptomycin</td> <td>Bone marrow suppression (dose-dependent) and DITP</td> </tr> <tr> <td>Dexamethasone</td> <td>DITP</td> </tr> <tr> <td>Diazoxide</td> <td>DITP</td> </tr> <tr> <td>Diclofenac</td> <td>DITP</td> </tr> <tr> <td>Diltiazem</td> <td>DITP</td> </tr> <tr> <td>Durvalumab</td> <td>DITP</td> </tr> <tr> <td><strong>Eptifibatide</strong></td> <td>DITP</td> </tr> <tr> <td>Ethambutol</td> <td>DITP</td> </tr> <tr> <td>Ethosuximide</td> <td>DITP</td> </tr> <tr> <td>Exenatide</td> <td>DITP</td> </tr> <tr> <td>Felbamate</td> <td>DITP</td> </tr> <tr> <td>Fluorouracil</td> <td>DITP</td> </tr> <tr> <td>Furosemide</td> <td>DITP</td> </tr> <tr> <td><strong>Gold compounds</strong></td> <td>DITP that may persist after the drug is stopped</td> </tr> <tr> <td>Haloperidol</td> <td>DITP</td> </tr> <tr> <td><strong>Heparin</strong></td> <td>Drug-dependent antibodies that also activate platelets and are associated with thrombosis</td> </tr> <tr> <td>Ibuprofen</td> <td>DITP; in some patients, antibodies react with the unmodified drug; in others, antibodies only react with a drug metabolite</td> </tr> <tr> <td>Influenza vaccine (trivalent, inactivated)</td> <td>DITP</td> </tr> <tr> <td>Intravenous immune globulin (IVIG)</td> <td>DITP</td> </tr> <tr> <td>Ipilimumab</td> <td>ITP<sup>¶</sup></td> </tr> <tr> <td>Irinotecan</td> <td>DITP</td> </tr> <tr> <td>Leucovorin</td> <td>DITP</td> </tr> <tr> <td>Levofloxacin</td> <td>DITP</td> </tr> <tr> <td><strong>Linezolid</strong></td> <td>Bone marrow suppression (dose-dependent)</td> </tr> <tr> <td><strong>MMR vaccine</strong></td> <td>ITP</td> </tr> <tr> <td>Mirtazapine</td> <td>DITP</td> </tr> <tr> <td>Naproxen</td> <td>DITP; antibodies react with a drug metabolite, not the unmodified drug</td> </tr> <tr> <td>Natalizumab</td> <td>ITP</td> </tr> <tr> <td>Nivolumab</td> <td>ITP<sup>¶</sup></td> </tr> <tr> <td>Ondansetron</td> <td>DITP</td> </tr> <tr> <td>Oseltamivir</td> <td>DITP</td> </tr> <tr> <td>Oxaliplatin</td> <td>DITP</td> </tr> <tr> <td>Palonosetron</td> <td>DITP</td> </tr> <tr> <td>Pembrolizumab</td> <td>ITP<sup>¶</sup></td> </tr> <tr> <td>Penicillin</td> <td>DITP</td> </tr> <tr> <td><strong>Phenytoin</strong></td> <td>DITP</td> </tr> <tr> <td><strong>Piperacillin</strong></td> <td>DITP</td> </tr> <tr> <td>Pyrazinamide</td> <td>DITP</td> </tr> <tr> <td>Quetiapine</td> <td>DITP</td> </tr> <tr> <td><strong>Quinidine</strong></td> <td>DITP</td> </tr> <tr> <td><strong>Quinine</strong><sup>Δ</sup></td> <td>DITP</td> </tr> <tr> <td><strong>Rifampin</strong></td> <td>DITP</td> </tr> <tr> <td>Simvastatin</td> <td>DITP</td> </tr> <tr> <td><strong>Sulfonamides</strong></td> <td>DITP</td> </tr> <tr> <td>Suramin</td> <td>DITP</td> </tr> <tr> <td>Tacrolimus</td> <td>DITP</td> </tr> <tr> <td>Teicoplanin</td> <td>DITP</td> </tr> <tr> <td><strong>Tirofiban</strong></td> <td>DITP</td> </tr> <tr> <td>Trastuzumab</td> <td>DITP</td> </tr> <tr> <td><strong>Trimethoprim-sulfamethoxazole</strong></td> <td>DITP; antibodies to both components have been identified</td> </tr> <tr> <td><strong>Valproic acid</strong></td> <td>Bone marrow suppression (dose-dependent)</td> </tr> <tr> <td><strong>Vancomycin</strong><sup>◊</sup></td> <td>DITP</td> </tr> <tr> <td>Volanesorsen</td> <td>Unknown</td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>This table lists drugs with evidence for a causal association with isolated thrombocytopenia; certain foods and beverages (eg, quinine-containing beverages, certain herbal teas, walnuts) can also cause thrombocytopenia. The drugs listed in this table come from clinical data in published case reports, identification of drug-dependent, platelet-reactive antibodies, or both; it also lists their mechanisms.</p>
Criteria for evaluating reports of a drug-induced etiology include:
<ul class="decimal_heading">
<li>Use of the drug preceded development of thrombocytopenia <em>and</em> platelet count recovery was sustained and complete following drug discontinuation.</li>
<li>No other drugs were used prior to development of thrombocytopenia <em>or</em> platelet count remained normal despite continuation or reintroduction of other drugs.</li>
<li>Other etiologies for thrombocytopenia were eliminated.</li>
<li>Re-exposure to the candidate drug caused recurrent thrombocytopenia <em>or</em> drug-dependent antiplatelet antibodies were demonstrated.</li>
</ul>
<p class="extra_spacing">Drugs in <strong>bold</strong> have been most commonly implicated in a causal relationship. Drug-dependent antibodies have been shown for all agents associated with DITP with the exceptions of aspirin, ethosuximide, exenatide, filgrastim, and <span class="nowrap_whitespace">linezolid.<sup>[1,2]</sup></span></p>
Refer to UpToDate for additional information on drug-induced thrombocytopenia.</div><div class="graphic_footnotes"><p>DITP: drug-induced immune thrombocytopenia, caused by drug-dependent antibodies; ITP: immune thrombocytopenia, caused by an autoimmune mechanism that no longer requires the presence of the drug; COVID-19: coronavirus disease 2019; VITT: vaccine-induced immune thrombotic thrombocytopenia; MMR: measles, mumps, and rubella.</p>
<p>* ITP is a rare adverse reaction to alemtuzumab. Thrombocytopenia typically presents months after alemtuzumab exposure and responds well to standard ITP therapies.</p>
<p>¶ Thrombocytopenia may occur when the patient is not actively on the drug; it often responds to standard ITP therapies.</p>
<p>Δ Quinine can also cause a thrombotic microangiopathy and/or other cytopenias.</p>
◊ In addition to parenteral formulations, vancomycin may be present in orthopedic cement used for joint replacement.</div><div class="graphic_reference">References:
<ol>
<li>Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data. Am J Hematol 2019; 94:E76.</li>
<li>Nusrat S, Borogovac A, George JN, et al. Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features. Am J Hematol 2022; 97:E162.</li>
</ol></div><div id="graphicVersion">Graphic 73618 Version 23.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
